ArcherDX Blog



Oct
2
2017

Input considerations for TCR and BCR sequencing

NGS is a powerful method to investigate the immune repertoire, and using RNA as the starting material has several advantages over DNA. Plus, sample-specific cell distributions and cell type-specific mRNA variations should be considered when analyzing the functional immune repertoire to minimize erroneous clonotyping.


Sep
12
2017

Archer® Analysis tool: CNV Visualization in v5.1

The CNV visualization tool within Archer Analysis was designed to maximize analytical capabilities for a variety of NGS library preparations. By giving the user the ability to customize the sensitivity settings based on assay and normalization requirements, copy number gains and losses, in addition to novel variants, can be detected with exon-level resolution and effortlessly tracked within the database.


Sep
8
2017

FLT3-ITD Detection Tech Note

ArcherDX scientists developed Archer® VariantPlex® myeloid assays to detect FLT3-ITDs, along with other myeloid-specific variants, by targeted next-generation sequencing (NGS). A new technical note discusses how Anchored Multiplex PCR (AMP™) chemistry in conjunction with the data-optimized analysis algorithm in Archer Analysis enable accurate detection of FLT3-ITDs across all sizes and insertion sites from clinical-type samples with 100% accuracy.


Aug
14
2017

AMPlify your immune repertoire sequencing

AMP enrichment chemistry and Archer Analysis software reduce PCR bias and minimize PCR and sequencing errors that plague amplicon-based approaches by delivering reliable BCR and TCR sequencing. Immunoverse TCR and BCR kits enable quantitative and sensitive clonotype detection, with sequences detectable at fractions as low as one in a million. Coupled with the fully automated Archer Analysis software and user-owned data, a wide variety of research applications are available to you.


Jul
28
2017

ArcherDX expands blood-based mutation assay portfolio with new myeloid panels

ArcherDX launches two new NGS-based NGS-based variant-detection assays, the 37-gene VariantPlex Core Myeloid and 72-gene VariantPlex Myeloid panel with unprecedented levels of confident mutation detection.


Jun
22
2017

ArcherDX presents at EHA 2017 in Madrid, Spain

ArcherDX presents at the 22nd European Hematology Association Congress in Madrid, Spain


May
11
2017

Archer sponsors Breast Cancer research platform

ArcherDX is partnering with Susan G. Komen Colorado and the University of Colorado Cancer Center to create a local event to connect community physicians, patients, and advocates with academic researchers and industry leaders. Our vision is to provide an educational forum to raise awareness about advances in breast cancer research, treatment, and testing.


May
12
2017

Archer at Immunology 2017

Archer exhibits at the American Association of Immunologists Annual Meeting–Immunology 2017 in Washington, DC. At the largest annual gathering of immunologists worldwide, scientists discuss breakthroughs across the full spectrum of topics in the Immunology.


May
5
2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.